Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Per KFF 2025, 43% of firms with 5,000-plus employees cover weight-loss GLP-1s (up from 28%), but only 30% of firms with 1,000 to 4,999 employees and 16% of firms with 200 to 999
It is often the first injectable medication people encounter when exploring medical weight loss
This event will trigger a 70% price collapse, transitioning Semaglutide from an elite luxury to a mass-market staple
HbA1c is the established gold standard for assessing glycaemic control in T2DM
US$ 24.96
US$ 26.26
US$ 27.53
US$ 21.10
US$ 21.25
